Tianjin TEDA Biomedical Engineering Co (HKSE:08189) Total Equity : HK$63.6 Mil (As of Jun. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Tianjin TEDA Biomedical Engineering Co Total Equity?

Tianjin TEDA Biomedical Engineering Co's total equity for the quarter that ended in Jun. 2024 was HK$63.6 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Tianjin TEDA Biomedical Engineering Co Total Equity Historical Data

The historical data trend for Tianjin TEDA Biomedical Engineering Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin TEDA Biomedical Engineering Co Total Equity Chart

Tianjin TEDA Biomedical Engineering Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Equity

Get a 7-Day Free Trial

183.91

135.13

90.62

70.64

30.37

Tianjin TEDA Biomedical Engineering Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Total Equity	Get a 7-Day Free Trial															76.30	-	70.64	63.57	30.37

Tianjin TEDA Biomedical Engineering Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Tianjin TEDA Biomedical Engineering Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	331.719	-	261.083
	=	70.6

Tianjin TEDA Biomedical Engineering Co's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2024 )	-	Total Liabilities(Q: Jun. 2024 )
	=	333.786	-	270.21
	=	63.6

Tianjin TEDA Biomedical Engineering Co Total Equity Related Terms

Thank you for viewing the detailed overview of Tianjin TEDA Biomedical Engineering Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin TEDA Biomedical Engineering Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Tianjin TEDA Biomedical Engineering Co Ltd (HKSE:08189) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 80, The 4th Avenue, 9th Floor, Block A2, Tianda Hi-Tech Park, TEDA Tianjin, Tianjin, CHN

Website

http://www.bioteda.com

Tianjin TEDA Biomedical Engineering Co Ltd is engaged in the research, development, and commercialization of biological compound fertilizers, providing elderly and health care services. It operates in two segments namely; biological compound fertilizers products, and elderly care and health care services. The company generates a majority of its revenue from the Fertilisers products segment which is engaged in manufacturing and selling biological compound fertiliser products, including active fertiliser, mixture with nitrogen, phosphorus, and potassium with various formulas, providing warehousing services, and processing and licensing of the fertiliser products. The People's Republic of China is the primary geographical market for the company.

Executives

Long Ortiz

2101 Beneficial owner

Tianjin TEDA Biomedical Engineering Co Headlines

No Headlines